» Articles » PMID: 38110380

Shared Decision-making Improving Efficacy in Diarrhoea-dominant Irritable Bowel Syndrome in Chinese Outpatient Setting: Protocol of a Prospective, Randomised Controlled Trial

Overview
Journal BMJ Open
Specialty General Medicine
Date 2023 Dec 18
PMID 38110380
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Diarrhoea-dominant irritable bowel syndrome (IBS-D) is a disorder with multiple pathogenesis; many people with IBS-D may have psychosocial issues which can make assessment and treatment more difficult. Routine treatment procedure might not always achieve the desired outcome. Therefore, patients may not be satisfied with the conventional experience and would like to be more involved in clinical decision-making. A shared decision-making (SDM) model, that requires patient participation, has been demonstrated to have a powerful effect on the diagnosis and treatment of other diseases, which improves patients' compliance, satisfaction, thus refining the clinical outcome. However, there is no corresponding evidence in IBS-D. Herein, we hope to verify the effect of SDM through clinical studies, and we anticipate that SDM can improve the therapeutic effect in patients with IBS-D.

Methods: The study is a prospective, randomised, single-centre trial. 166 IBS-D outpatients who attend Peking Union Medical College Hospital will be allocated into routine treatment group and SDM group. The primary endpoint is the severity of bowel symptoms, measured by the IBS symptom severity scale. Secondary endpoints include impact of disease and quality of life, negative psychology and the evaluation of diagnosis and treatment process.

Ethics And Dissemination: Ethical approval has been obtained from the research ethics committee of Peking Union Medical College Hospital (I-23PJ470). This protocol has been approved by Chinese Clinical Trial Register (ChiCTR2300073681) in July 2023. The results of this trial will be published in an open-access way and disseminated among gastrointestinal physicians.

Trial Registration Number: Chinese Clinical Trial Register (ChiCTR2300073681).

References
1.
Chewning B, Bylund C, Shah B, Arora N, Gueguen J, Makoul G . Patient preferences for shared decisions: a systematic review. Patient Educ Couns. 2011; 86(1):9-18. PMC: 4530615. DOI: 10.1016/j.pec.2011.02.004. View

2.
OConnor A . Validation of a decisional conflict scale. Med Decis Making. 1995; 15(1):25-30. DOI: 10.1177/0272989X9501500105. View

3.
Lee H, Hsieh J, Lu C, Yeh T, Tu C, Cheng C . Enhanced affect/cognition-related brain responses during visceral placebo analgesia in irritable bowel syndrome patients. Pain. 2012; 153(6):1301-1310. DOI: 10.1016/j.pain.2012.03.018. View

4.
Elwyn G, Tsulukidze M, Edwards A, Legare F, Newcombe R . Using a 'talk' model of shared decision making to propose an observation-based measure: Observer OPTION 5 Item. Patient Educ Couns. 2013; 93(2):265-71. DOI: 10.1016/j.pec.2013.08.005. View

5.
Everitt H, Landau S, OReilly G, Sibelli A, Hughes S, Windgassen S . Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial. Gut. 2019; 68(9):1613-1623. PMC: 6709776. DOI: 10.1136/gutjnl-2018-317805. View